Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy. (2016)

First Author: Ricotti V
Attributed to:  MICA: The role of utrophin in DMD and its therapeutic potential funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0152840

PubMed Identifier: 27055247

Publication URI: http://europepmc.org/abstract/MED/27055247

Type: Journal Article/Review

Volume: 11

Parent Publication: PloS one

Issue: 4

ISSN: 1932-6203